BioSpace News Archive

Policy

Endo Announces FDA Decision Not to Include Vasopressin on 503B Bulks List

Endo International plc announced that the U.S. Food and Drug Administration has determined that there is no clinical need to compound vasopressin under Section 503B of the Drug Quality and Security Act.

March 1, 2019
·
3 min read
Business

Apotex Corp. Issues Voluntary Nationwide Recall of Drospirenone and Ethinyl Estradiol Tablets, USP, 28x3 blister pack/carton due to possibility of missing/incorrect tablet arrangement

Apotex Corp. is voluntarily recalling four lots of Drospirenone and Ethinyl Estradiol Tablets, USP to the patient /user level.

March 1, 2019
·
3 min read
Biotech Beach

Axiom Foods Solves the Taste Issue: Totally Neutral Flavor & Aroma Pea Protein Is Also Proven to Be a Complete Protein

An Industry First, Axiom’s Global and Patent Pending Innovation Leads the Way

March 1, 2019
·
3 min read
Deals

Quest Diagnostics Declares Quarterly Cash Dividend payable on April 22, 2019

Quest Diagnostics, the world’s leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.53 per share, payable on April 22, 2019 to shareholders of record of Quest Diagnostics common stock on April 8, 2019.

March 1, 2019
·
1 min read
Biotech Beach

4th Annual CEO Summit Scheduled for March 6, 2019 During the Natural Products Expo

Natural Industry Leaders Bring Forth Behind the Scenes Issues that Affect Consumers: Hear The 411 on 420, From a 13-Year-Old Kid-Preneur, Former FDA Regulator and about Fake Organics

March 1, 2019
·
5 min read